ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2014
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Tax Payment
Common Stock
2013-12-31$4.34/sh−7,193$31,218→ 45,594 total - Award
Employee Stock Option (Right to Buy)
2013-12-31+150,000→ 150,000 totalExercise: $4.34Exp: 2023-12-31→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]50,000 shares shall vest on each of 12/31/2014; 12/31/2015 and 12/31/2016.